165
Views
14
CrossRef citations to date
0
Altmetric
Review

Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy

, MD PhD & , MD FRCP
Pages 31-41 | Published online: 20 Dec 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chi Chiu Mok. (2010) Update on emerging drug therapies for systemic lupus erythematosus. Expert Opinion on Emerging Drugs 15:1, pages 53-70.
Read now

Articles from other publishers (12)

Guang-ping Ruan, Xiang Yao, Shuang-juan Yang, Jin-xiang Wang, Fan Shu, Zi-an Li, Ju-fen Liu, Rong-qing Pang & Xing-hua Pan. (2014) Transplanted Human Umbilical Cord Mesenchymal Stem Cells Facilitate Lesion Repair in B6.Fas Mice. Journal of Immunology Research 2014, pages 1-13.
Crossref
Iñigo Rúa-Figueroa, Francisco Javier López-Longo, Jaime Calvo-Alén, María Galindo-Izquierdo, Estíbaliz Loza, M. Jesús García de Yebenes & José M. Pego-Reigosa. (2014) National Registry of Patients With Systemic Lupus Erythematosus of the Spanish Society of Rheumatology: Objectives and Methodology. Reumatología Clínica (English Edition) 10:1, pages 17-24.
Crossref
Iñigo Rúa-Figueroa, Francisco Javier López-Longo, Jaime Calvo-Alén, María Galindo-Izquierdo, Estíbaliz Loza, M. Jesús García de Yebenes & José M. Pego-Reigosa. (2014) Registro nacional de pacientes con lupus eritematoso sistémico de la Sociedad Española de Reumatología: objetivos y metodología. Reumatología Clínica 10:1, pages 17-24.
Crossref
Lucie Abeler-Dörner, Cosima C. Rieger, Bartlomiej Berger, Heiko Weyd, Daniela Gräf, Sandra Pfrang, Ingo H. Tarner, Andreas Schwarting, Hanns-Martin Lorenz, Ulf Müller-Ladner, Peter H. Krammer & Annegret Kuhn. (2013) Interferon-α Abrogates the Suppressive Effect of Apoptotic Cells on Dendritic Cells in an In Vitro Model of Systemic Lupus Erythematosus Pathogenesis . The Journal of Rheumatology 40:10, pages 1683-1696.
Crossref
Venkat Reddy, David Jayne, David Close & David Isenberg. (2013) B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design. Arthritis Research & Therapy 15:Suppl 1, pages S2.
Crossref
Yiyun Yu & Antonio La Cava. (2011) Current drugs in systemic lupus erythematosus. Drug Development Research 72:7, pages 561-572.
Crossref
L. Sun. (2010) Stem cell transplantation: progress in Asia. Lupus 19:12, pages 1468-1473.
Crossref
Jiahui Yang, Richard Pospisil, Satyajit Ray, Jacqueline Milton & Rose G. Mage. (2009) Investigations of a Rabbit (Oryctolagus cuniculus) Model of Systemic Lupus Erythematosus (SLE), BAFF and Its Receptors. PLoS ONE 4:12, pages e8494.
Crossref
Voravit Ratanatharathorn, Steven Pavletic & Joseph P. Uberti. (2009) Clinical applications of rituximab in allogeneic stem cell transplantation: Anti-tumor and immunomodulatory effects. Cancer Treatment Reviews 35:8, pages 653-661.
Crossref
Lingyun Sun, Kentaro Akiyama, Huayong Zhang, Takayoshi Yamaza, Yayi Hou, Shengnan Zhao, Ting Xu, Anh Le & Songtao Shi. (2009) Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans. Stem Cells 27:6, pages 1421-1432.
Crossref
Jiahui Yang, Richard Pospisil & Rose G. Mage. (2009) Expression and localization of rabbit B-cell activating factor (BAFF) and its specific receptor BR3 in cells and tissues of the rabbit immune system. Developmental & Comparative Immunology 33:5, pages 697-708.
Crossref
Catherine A. Heyneman. (2008) Systemic Lupus Erythematosus: A Therapeutic Update. Journal of Pharmacy Practice 22:1, pages 29-52.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.